Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Protagonist Therapeutics

Market Cap: US$5.4b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Ginkgo Bioworks Holdings

Market Cap: US$468.3m

Develops a platform for cell programming in the United States.

Perrigo

Market Cap: US$1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Rigel Pharmaceuticals

Market Cap: US$758.2m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Natera

Market Cap: US$31.1b

A diagnostics company, provides molecular testing services worldwide.

Plus Therapeutics

Market Cap: US$75.8m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

AFT Pharmaceuticals

Market Cap: NZ$367.0m

Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Vicore Pharma Holding

Market Cap: SEK 2.8b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

LENZ Therapeutics

Market Cap: US$534.1m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Kyverna Therapeutics

Market Cap: US$306.6m

A clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.

UroGen Pharma

Market Cap: US$1.0b

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Cue Biopharma

Market Cap: US$26.9m

A clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States.

High Tide

Market Cap: CA$335.4m

Engages in the cannabis retail business in Canada.

Atai Beckley

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Immutep

Market Cap: AU$582.1m

A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Cohance Lifesciences

Market Cap: ₹206.0b

Engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally.

Gerresheimer

Market Cap: €931.2m

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Prescient Therapeutics

Market Cap: AU$95.7m

A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.

Caribou Biosciences

Market Cap: US$152.4m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

NanoViricides

Market Cap: US$21.8m

A clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections.

Dynavax Technologies

Market Cap: US$1.3b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

C4 Therapeutics

Market Cap: US$194.8m

A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.

Gossamer Bio

Market Cap: US$793.9m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

OSR Holdings

Market Cap: US$14.7m

A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea.

Wave Life Sciences

Market Cap: US$2.8b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Merus

Market Cap: US$7.3b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Exact Sciences

Market Cap: US$19.2b

Provides cancer screening and diagnostic test products in the United States and internationally.

Hyperion DeFi

Market Cap: US$24.5m

An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.

Granules India

Market Cap: ₹141.5b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

Divi's Laboratories

Market Cap: ₹1.7t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Blue Jet Healthcare

Market Cap: ₹92.2b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Belite Bio

Market Cap: US$5.8b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.

Cidara Therapeutics

Market Cap: US$6.9b

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Terns Pharmaceuticals

Market Cap: US$4.2b

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Incannex Healthcare

Market Cap: US$137.5m

A clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.

Emergent BioSolutions

Market Cap: US$646.0m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.